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Introduction: There is a practical need for the identification of robust cell-surface markers that can be used to enrich
for living keratinocyte progenitor cells. Breast cancer resistance protein (ABCG2), a member of the ATP binding cassette
(ABC) transporter family, is known to be a marker for stem/progenitor cells in many tissues and organs.
Methods: We investigated the expression of ABCG2 protein in normal human epidermis to evaluate its potential
as a cell surface marker for identifying and enriching for clonogenic epidermal keratinocytes outside the
pilosebaceous tract.
Results: Immunofluorescence and immunoblotting studies of human skin showed that ABCG2 is expressed in a
subset of basal layer cells in the epidermis. Flow cytometry analysis showed approximately 2-3% of keratinocytes
in non-hair-bearing epidermis expressing ABCG2; this population also expresses p63, β1 and α6 integrins and
keratin 14, but not CD34, CD71, C-kit or involucrin. The ABCG2-positive keratinocytes showed significantly higher colony
forming efficiency when co-cultured with mouse 3T3 feeder cells, and more extensive long-term proliferation capacity
in vitro, than did ABCG2-negative keratinocytes. Upon clonal analysis, most of the freshly isolated ABCG2-positive
keratinocytes formed holoclones and were capable of generating a stratified differentiating epidermis in organotypic
culture models.
Conclusions: These data indicate that in skin, expression of the ABCG2 transporter is a characteristic of interfollicular
keratinocyte progentior cells and suggest that ABCG2 may be useful for enriching keratinocyte stem cells in human
interfollicular epidermis.Introduction
Tissue stem cells or progenitor cells of the epidermis
have been identified in several specific niche locations
within the pilosebaceous unit of the skin [1-4]. These
cells are reported to be slow cycling or rarely cycling
cells during homeostasis in vivo, with a high capacity for
error-free self-renewal, and superior clonogenicity and
proliferation capacity [5-8]. Keratinocyte stem cells have
been detected by labeling the skin with titrated thymidine
or bromodeoxyuridine or by clonal analysis [2,9-11], or in
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unless otherwise stated.label cell populations containing stem cells. Several poten-
tial molecular markers for identifying keratinocyte stem
cells have been investigated, including β1-integrin, keratin
19, CD34, p63, α6briCD71dim, Rac1, MTS24 and survivin
[3,12-18]. Although some antibodies to CD71 (transfer-
ring receptor) and some integrins have been used to en-
rich for progenitor containing pools of cells, in most cases
it is difficult to use these methods for isolating living cells
for stem cell biology studies and clinical use, because cells
have to be fixed or permeabilized in order to access the
antigens. Moreover there is no clear identification marker
for human interfollicular epidermal progenitor cells, al-
though there is a need to identify and characterize these
cells for applications in cell and gene therapy [19].
ABCG2, also known as breast cancer resistance pro-
tein BCRP1 or CDw338, is a member of the ATP-s is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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from the White subfamily. Multidrug resistance proteins
are associated with resistance to chemotherapy and are
overexpressed in several cancer cell lines. ABCG2 is a
transmembrane transporter protein that clears xenobi-
otics from the cell and so confers drug resistance on
cells; it is expressed at high levels in the placenta, where
it plays a role in protecting the fetus from xenobiotics.
ABCG2 expression is also associated with a side popula-
tion (SP) cell phenotype observed during fluorescence-
activated cell sorting (FACS), due to the ability of
ABCG2-expressing cells in many tissues to clear
Hoechst 33342 dye from the cells [20-22]. Such ABCG2-
expressing SP cells have been demonstrated to show
characteristics of stem cells in many tissues and organs,
including the hematopoietic system, skeletal muscle,
mammary gland and limbus of the eye [23-29], and it
has been suggested that expression of the ABCG2 gene
is a conserved feature of stem cells from a wide variety
of tissues.
ABCG2 expression in the epidermis has not been in-
vestigated extensively, although this is a tissue in which
there is a high premium on stem cell enrichment (for
improved skin autograft generation to treat wounds). A
few studies have investigated SP keratinocytes using dye
exclusion [30-35]; but it is not known which cell types in
human interfollicular epidermis express the ABCG2
transporter protein, and whether such cells possess the
characteristics of stem cells [34]. In this study, we inves-
tigate the expression of ABCG2 in human epidermis ex-
ternal to hair follicles, and compare the properties of the
ABCG2-positive keratinocytes against unsorted keratino-
cytes in functional assays. We report that within interfol-
licular and nonhair-bearing epidermis, ABCG2 is
specifically expressed in the basal keratinocytes, and
ABCG2-positive keratinocytes showed similar stem cell-
like properties to other published stem cell marker-
identified keratinocyte populations. We demonstrate a
proof of concept that ABCG2 is a robust stem cell indi-
cator in human interfollicular keratinocytes that can be
practically used to enrich for keratinocyte stem cells.
Materials and methods
Isolation and cultivation of keratinocytes from human skin
Normal fresh human skin samples were obtained from
surgical waste from plastic surgery operations of healthy
subjects, with informed consent from these donors and
ethics approval from the ethics committee of Singapore
General Hospital. Human skin samples from neonatal
foreskins (6 donors) and adult scalp skin (4 donors) were
used in this study. Samples were washed in phosphate-
buffered saline (PBS) and incubated in 0.25% Dispase
II (Roche, Singapore) overnight at 4°C; epidermis was
separated from dermis with fine forceps. Epidermiswas then minced and incubated in 0.05% trypsin–
ethylenediamine tetraacetic acid (Gibco, Invitrogen,
Singapore) at 37°C for 15 minutes. Keratinocytes from
epidermis were collected and suspended in PBS and
filtered on a 40 μm filter (Falcon, Becton Dickinson,
Singapore) to obtain a single cell suspension before
counting and seeding.
Human skin keratinocytes were seeded at a density of
5 × 104 cells/cm2 on a layer of lethally gamma-irradiated
3T3-J2 mouse feeder cells as described previously [36].
The keratinocytes were cultured at 37°C in a 10% carbon
dioxide humidified atmosphere. The culture medium
used [36] was a mixture of Dulbecco’s modified Eagle’s
medium (DMEM; Gibco, Invitrogen) and Ham’s F12
(Gibco, Invitrogen) at a ratio of 3:1, containing 10% fetal
bovine serum (FBS; Hyclone, Logan, UT, USA), insulin
(5 μg/ml), adenine (0.18 mM), hydrocortisone (0.4 μg/ml),
cholera toxin (0.1 nM), triiodothyronine (2 nM), epider-
mal growth factor (10 ng/ml), L-glutamine (4 mM) and
penicillin–streptomycin (50 IU/ml). All reagents were
from Sigma (Singapore) unless specified. The culture
medium was changed every 3 days, and subconfluent cul-
tures were passaged by treating them with 0.05% trypsin
for 8 minutes at 37°C, collecting and counting keratino-
cytes and replating cells at a density of 5 × 103 cells/cm2.
Immunofluorescence staining of skin
Fresh human skin samples were embedded in OCT
embedding media (Sakura, Torrance, CA, USA). Frozen
sections of skin (5 μm) were cut with a cryostat (Leica,
Houston, TX, USA) and stored at −80°C until use. Im-
munofluorescence staining was performed as described
previously [32]. In brief, human skin sections were fixed
with 4% paraformaldehyde at 4°C for 15 minutes; after
blocking with 5% goat serum in PBS for 30 minutes, anti-
ABCG2 antibody (clone BXP-21; Millipore, Singapore)
was used at a 1:25 dilution in PBS at room temperature
for 1 hour. After washing with PBS three times,
Alexafluor-488 conjugated secondary antibody (1:200;
Gibco, Invitrogen) was applied for 1 hour in a dark cham-
ber. After washing with PBS three times, the slides were
mounted with Vectashield fluorescent mounting medium
containing 4′-6-diamidino-2-henylindole (Vector Labs,
Eon Biotech, Singapore) and covered with cover slips. The
slides were visualized and photographed with a fluorescent
microscope (Axiovert 200; Carl Zeiss, Singapore).
Immunoblot analysis
Each population of sorted ABCG2-positive, ABCG2-
negative keratinocytes and unsorted keratinocytes from
human epidermis were collected, centrifuged at 4°C, and
the cell pellets were homogenized in RIPA buffer (1%
Nonidet P-40, 0.5% sodium deoxycholate, 150 mM so-
dium chloride, 1 mM phenylmethylsulfonyl fluoride and
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quantified using a BCA kit (Pierce, Rockford, IL, USA).
An equal amount of protein was electrophoresed in a
7.5% SDS-polyacrylamide gel, transferred onto a nitrocel-
lulose membrane. The membrane was blocked with 2%
bovine serum albumin in Tris-buffered saline for 3 hours,
washed with Tris-buffered saline for 1 hour, and incubated
with anti-ABCG2 antibody (BXP-21, 1:100; Millipore)
diluted in Tris-buffered saline with 0.1% Tween-20 over-
night at 4°C. After washing, anti-mouse IgG (horseradish
peroxidase-conjugated, 1:2,000; Santa Cruz Technologies,
Santa Cruz, Biotechnologies Inc., Zoolem Marketing,
Singapore) was applied for 1 hour at room temperature.
Finally, chemiluminescence was carried with the Super-
signal chemiluminescent substrate (Pierce).
Flow cytometry analysis and fluorescence-activated cell
sorting
Freshly isolated human foreskin epidermis keratinocytes
were suspended at a concentration of 106 cells/ml in
staining medium (DMEM containing 2% FBS and
10 mM HEPES), incubated with anti-ABCG2 antibody
(clone 5D3, 1:25; BD Biosciences, Singapore) for 30 mi-
nutes on ice, washed with PBS containing 1% FBS, and
then incubated with Alexafluor-488 conjugated rabbit
anti-mouse secondary antibody (1:200; Gibco, Invitro-
gen) for 30 minutes, washed with PBS/1% FBS for 5 mi-
nutes three times, and resuspended in staining medium.
The cells were kept on ice until flow cytometry analysis
was performed. FACS was performed at the National
University Medical Institute (Singapore) with a FACSad-
vantage SE (BD Biosciences, Mountain View, CA, USA)
cell sorter.
To characterize the phenotype of ABCG2-positive and
ABCG2-negative keratinocytes, the sorted cells were
stained for 30 minutes at 4°C with anti-human antibodies
against α6-integrin (GoH3), β1-integrin (4B7R), CD34
(8G12), CD71 (C2), keratin 14 (RCK107, phycoerythrin-
conjugated, 1:100; all from BD Biosciences, USA), and p63
(4A4, 1:200; Santa Cruz Biotechnology Inc., Zoolem
Marketing, Singapore).
Clonal analysis
After sorting with anti-ABCG2 antibody, single keratino-
cytes were picked under an inverted microscope as de-
scribed previously [37], and seeded in a 35 mm Petri
dish containing a monolayer of lethally irradiated 3T3
feeder cells. After 7 days of culture, the colonies were
identified by phase contrast microscopy. Each colony
was then transferred to two 100 mm Petri dishes, with
25% of the cells in one plate (indicator plate for colony-
forming efficiency (CFE) assays) and the remaining 75%
of the cells in the second plate for further expansion. Se-
lected colonies from the second plate were cultivatedserially as above and were passaged as above until they
stopped proliferating.
Colony-forming efficiency assay
To evaluate the CFE, populations of ABCG2-positive,
ABCG2-negative and unsorted keratinocytes were col-
lected and 100 cells of each population were plated into
100 mm Petri dishes containing a layer of lethally irradi-
ated 3T3-J2 mouse feeder cells, and cultured as above
for 12 days. The culture medium was changed every
4 days. At the end of the culture period, cells were fixed
with formalin (see above) and stained with 1% Rhoda-
mine B. The CFE was calculated and expressed as a per-
centage of the number of plated cells.
Expansion assay
ABCG2-positive, ABCG2-negative and unsorted kerati-
nocytes were cultured on lethally irradiated 3T3 feeder
cells. After keratinocytes reached 70 to 80% confluence,
cells were trypsinized and seeded at a density of 5,000
cells/cm2. Cultures were serially passaged until the pro-
liferation capacity of the keratinocytes was exhausted.
The number of population doublings was calculated ac-
cording to the following formula:
Population doublings = (log N / N0) / log2
where N represents the total number of cells obtained
at each passage and N0 represents the number of cells
plated at the start of the experiment.
RNA isolation and RT-PCR analysis
Total RNA from ABCG2-positive, ABCG2-negative and
unsorted keratinocytes was isolated using the RNeasy kit
(Gibco, Invitrogen). The RNA was quantified by its
absorption at 260 nm using a NanoDrop spectropho-
tometer (ND-1000; NanoDrop Technologies, Thermo
Scientific, Singapore) and stored at −80°C until use. A
housekeeping gene, glyceraldehyde-3-phosphate de-
hydrogenase, was used as an internal control. The
mRNA expression level of different molecular markers
was analyzed by semiquantitative RT-PCR as described
previously [20]. Briefly, 1 μg total RNA was used to
synthesize first-strand cDNAs with Superscript first-
strand System (Gibco, Invitrogen). PCR amplification
was performed with specific primer pairs designed from
published human gene sequences for different markers
[20]. The fidelity of the RT-PCR products was verified
by comparing their size with expected cDNA bands and
sequencing the PCR products. The PCR products were
also visualized on 1.8% agarose gel.
Reconstructing epidermis with organotypic culture
Glycerol-preserved allogenic skin (Euro Skin Bank, EA
Beverwijk, the Netherlands) was used and washed in
PBS containing penicillin–streptomycin (50 IU/ml). The
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of snap-freezing and thawing. The de-epidermized der-
mis was cut into 2 × 2 cm squares, and a 1 cm diameter
stainless steel ring was placed on the reticular side of
each dermis square. Normal primary human dermal fi-
broblasts were seeded onto the dermis at 5 × 105 cells
per ring and grown for 1 day in DMEM supplemented
with 10% FBS, L-glutamine (4 mM) and penicillin–
streptomycin (50 IU/ml). ABCG2-positive and ABCG2-
negative keratinocytes were then plated on top at 2 × 105
cells per ring respectively, and cultured in keratinocyte
culture medium for 4 days to reach a confluent mono-
layer. The cultures were then raised to the air–liquid
interface and cultured for a further 10 days. The cultures
were embedded in OCT and snap frozen in liquid nitro-
gen; frozen sections were cut at 5 μm and stained with
hematoxylin and eosin.
Preparation of cultured epidermal grafts and grafting to
nude mice
The protocol for preparation of cultured epidermal
grafts was adopted from a previous study [38]. Cultured
epidermal grafts were prepared in a six-well plate. In
brief, 10 ml pig plasma was mixed with 100,000 human
skin dermal fibroblasts (0.5 million/ml) supplemented
with 13 ml of 0.9% NaCl solution. This mixture (total
23 ml) was carefully added to 2 ml of 1% CaCl2 solution,
and the mixture solution was pipetted into a six-well
plate at 4 ml/well. The six-well plate was transferred to
a carbon dioxide incubator at 37°C, where the mixture
solidified within 15 minutes. Then 3 ml DMEM+ 10%
FBS was added to each well. ABCG2-positive, ABCG2-
negative keratinocytes, unsorted keratinocytes or α6-
integrin-positive keratinocytes were then seeded onto the
plasma gel 16 to 24 hours later and cultured to confluence.
All animal studies were carried out with the approval
of the Singhealth Institutional Animal Care and Use
Committee in Singhealth Experimental Medical Center
under specific pathogen-free conditions. Nude athymic
BALB/c nu/nu mice 6 to 8 weeks old (purchased from
Animal Resources Center, Perth, Western Australia)
were used as skin graft recipients. Each animal was asep-
tically cleansed and a full-thickness 3 cm circular skin
wound was made on the dorsum, into which a cultured
epidermal graft, detached from the culture well, was
placed. The wound was covered with the excised skin
that had been de-vitalized by four cycles of freezing and
thawing, sutured in place to act as wound dressing to
protect and fix the skin grafts. To further protect the
graft site, surgical normal gauze was applied on top of
the devitalized skin, followed by several layers of stand-
ard dressing gauze. Antibiotics (Baytril®, enrofloxacin:
Bayer Healthcare, Singapore; 120 mg/kg in drinking
water) were given at the time of grafting and werecontinued for the next 5 days. After transplantation, ani-
mals were observed each day, and the wound dressings
were changed every 2 days. The wound dressings were
removed when the regenerated epidermis was robust
enough, usually 3 to 4 weeks after transplantation. The
mice were further maintained up to 20 weeks. The re-
generated human epidermal grafts were biopsied at dif-
ferent time intervals, snap frozen in liquid nitrogen, and
8 μm frozen sections were prepared for hematoxylin and
eosin staining.
Statistical analysis
The CFE data were calculated as a mean value (triplicate) ±
standard error of the mean, as indicated. Differences be-
tween mean values were analyzed with Student’s t test, and
P <0.05 was considered statistically significant.
Results
ABCG2 expression is restricted to the basal layer of
human skin epidermis
By immunohistochemistry of human skin sections,
ABCG2 protein was detected in a range of sites previ-
ously associated with locations rich in keratinocyte
progenitor/stem cells in the hair follicle, as well as in the
small cells of the basal layer keratinocytes in interfollicu-
lar epidermis (Figure 1A,F), and both membrane-
associated and cytoplasmic staining were observed. No
ABCG2 expression was detected in suprabasal keratino-
cytes (Figure 1B). There was minimal ABCG2 staining in
the dermis. The staining pattern is similar to that of sev-
eral other progenitor markers in the epidermis, such as
the transcription factor p63: positive staining was seen
in isolated small clusters of basal keratinocytes, inter-
spersed with large areas of unstained cells [15]. This
staining pattern is similar to previous reports of ABCG2
staining in mouse skin and human limbus [28,32]. Im-
munoblot analysis revealed a single protein band with a
molecular weight of approximately 72 kDa that was de-
tected in any samples from whole skin, epidermis,
ABCG2-positive keratinocytes or A549 cells (Figure 2A).
As expected, the highest expression of ABCG2 was de-
tected in ABCG2-positive keratinocytes sorted by FACS,
followed by epidermis and whole skin, while dermis
expressed little if any ABCG2. These results show that
in human interfollicular epidermis, ABCG2 is predomin-
antly expressed in the basal layer keratinocytes.
To estimate the proportion of ABCG2-expressing
basal keratinocytes in skin epidermis, flow cytometry
analysis was performed using the anti-ABCG2 antibody
(clone 5D3; eBioscience, BD Biosciences, Singapore).
ABCG2-positive keratinocytes accounted for 2.7 ± 0.6%
(mean ± standard deviation, n = 5; Figure 2C, region M1)
of freshly isolated keratinocytes, and 2.8 ± 0.3% (mean
± standard deviation, n = 5; Figure 2D, region M1) of
Figure 1 Localization of ABCG2 in human interfollicular skin and hair follicle by immunofluorescence staining of human interfollicular
epidermis and hair follicle with anti-ABCG2 antibody (clone BXP-21). Bright green cell membrane staining of ABCG2 was seen in clusters of
small cells of basal layer keratinocytes (white arrow) in human skin (A, B) and hair follicle (D, E, F), whereas suprabasal keratinocytes were unstained
stained. (B) High magnification of (A). (E) High magnification of (D). (C) Human interfollicular skin was stained with anti-keratin15 antibody (clone LHK15),
and most basal cells were positively stained (green) on their cell membrane. Cell nuclei were counterstained with 4′-6-diamidino-2-phenylindole DAPI:
(blue). Original magnification: A, D, F, ×10; and B, C, E, ×20. Scale Bars: A, D, F, 50 μm; and B, C, E, 50 μm.
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sion in the cells sorted by FACS was confirmed by com-
paring the levels of ABCG2 mRNA detected by RT-PCR
in ABCG2 antibody-positive and antibody-negative popu-
lations. ABCG2 mRNA was highly expressed in the
antibody-positive population and A549 cell line, which
was taken as a positive control, whereas mRNA was barely
detectable in the ABCG2 protein-negative population.
There was no difference in glyceraldehyde-3-phosphate
dehydrogenase expression among these three groups
(Figure 2B).
Phenotype of ABCG2-positive keratinocytes
The phenotype of ABCG2-positive and ABCG2-negative
keratinocytes was determined by examining the expres-
sion of several known growth and differentiation status
markers. As shown in Figure 3A and Table 1, ABCG2-
positive keratinocyte populations were also strongly
stained with antibodies to α6-integrin, β1-integrin, keratin
14 and p63, compared with ABCG2-negative keratino-
cytes, whereas ABCG2-positive keratinocytes were weakly
stained by CD34, CD71, C-Kit and involucrin antibodies
when compared with ABCG2-negative keratinocytes.
These data suggest that ABCG2-positive keratinocytes ex-
press high levels of several potential stem cell markers,
while expressing low levels of differentiation markers.Colony-forming efficiency assay and clonal analysis
Next we examined the CFE and the colony morpholo-
gies produced by each population of ABCG2-positive/
negative keratinocytes sorted by FACS. ABCG2-positive
and ABCG2-negative keratinocytes were seeded at a
density of 100 cells per 100 mm culture containing a
layer of lethally irradiated 3T3 feeder cells, and keratino-
cytes were cultured for 12 days. The colony types pro-
duced by the two sorted keratinocyte populations were
very obviously different. Figure 3B,C shows examples of
the different colonies observed in ABCG2-positive and
ABCG2-negative keratinocyte cultures. Large colonies were
observed in ABCG2-positive cultures but not in the
ABCG2-negative cultures (Figure 3B). Also, most of the
colonies formed by the ABCG2-positive population were
composed of small actively growing keratinocytes
(Figure 3B), while most of the cells in ABCG2-negative
colonies were very large and mostly abortive within 4 weeks
(Figure 3C).
As shown in Figure 4A,F, the CFE values for ABCG2-
positive, ABCG2-negative and unsorted keratinocytes
were 85% ± 2.1%, 27% ± 1.8% and 31 ± 2.3% respectively.
The ABCG2-positive keratinocytes exhibited statistically
higher CFE and larger colony sizes, as compared with
ABCG2-negative keratinocytes and unsorted cells (P <0.01,
n = 5; Figure 4F). No difference in CFE was found between
Figure 2 Localization of ABCG2 in human skin by western blot, RT-PCR assay and flow cytometry analysis. (A) Western blot analysis of
ABCG2 expression in human skin. Epidermis and positive control (A549 cell line) expressed ABCG2, dermis tissue did not; a lower level of ABCG2
staining was detected in whole unfractionated skin. (B) RT-PCR analysis of ABCG2 mRNA expression in sorted keratinocytes. Higher expression of ABCG2
mRNA (379 base pairs (bp)) was shown in ABCG2-positive keratinocytes sorted by fluorescence-activated cell sorting, while lower expression of ABCG2
mRNA was shown in ABCG2-negative keratinoctyes. A 100 bp DNA ladder is shown in the first left lane. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; 498 bp) was used as an internal control. (C) Fresh isolated epidermal keratinocytes were incubated with anti-ABCG2 antibody (clone 5D3), and
Alexafluor-488 conjugated secondary antibody was used. ABCG2-positive cells (green line, region M1) accounted for approximately 2.7%; isotype control,
blue line; blank control, red line. (D) Primary cultured epidermal keratinocytes were harvested and incubated with anti-ABCG2 antibody; approximately
2.8% of cells showed ABCG2-positive staining (green line, region M1). The flow analyses were repeated five times, and the results were averaged.
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Figure 4F).
To investigate the clonogenic potential of ABCG2-
positive keratinocytes versus ABCG2-negative keratinocytes,
single cell clones from each population were isolated, ex-
panded and assayed for their ability to generate clones with
high proliferation potential as would be expected for a stem
cell. In total, 300 clones from five donors were analyzed for
their ability to generate colonies identified as holoclones,
paraclones and meroclones [37]. We found that 73.7 ± 1.2%
of clones from ABCG2-positive keratinocytes were holo-
clones, whilst meroclones and paraclones represented less
than 27%. For ABCG2-negative cells, the holoclones were
less than 4%, and 95% of the clones were meroclones and
paraclones (Table 2, Figure 4G). The holoclones, meroclones
and paraclones [34] obtained from the same donors were
then cultivated serially to evaluate their proliferative capacity
(Table 3). The holoclones were found to produce 120 to 140
cell generations before they stopped proliferating, while
meroclones were able to undergo 20 to 42 cell divisions and
paraclones only underwent five to 10 cell divisions before
exhausting their proliferation capacity (Figure 5A).Epidermal reconstruction assay
We also compared the ability of each population to dif-
ferentiate and regenerate a multilayered epidermis.
ABCG2-positive and ABCG2-negative keratinocytes
sorted by FACS were plated onto a de-epidermized der-
mis substrate. As shown in Figure 4B, the ABCG2-
positive cells were able to form a stratified epithelium
typical of a normal epidermal structure and cellular differ-
entiation: a basal layer with polygonal keratinocytes ori-
ented perpendicularly to the underlying de-epidermized
dermis, three to four layers of spinous cells, three to four
layers of granular cells characterized by the presence of
keratohyalin granules, and layers of anucleate, flattened
cornified cells forming a compact stratum corneum. In
contrast, ABCG2-negative cells only formed an irregular
and disorganized epidermis with two to three layers of
keratinocytes (Figure 4C). The organotypic structure
formed by the ABCG2-positive cells was thicker than a
normal steady-state in vivo epidermis, and this was attrib-
uted to the high proportion of clonogenic cells used to ini-
tiate the organotypic construct. Immunostaining of the
culture from these two groups with anti-involucrin
Figure 3 Phenotype of ABCG2-positive keratinocytes. (A)
Expression of stem cell markers in human epidermal keratinocytes.
ABCG2-positive and ABCG2-negative keratinocytes were sorted
separately as in Figure 2. ABCG2-positive cells (blue line) were more
strongly stained with antibodies to α6-integrin, β1-integrin, keratin 14
and p63 than ABCG2-negative cells (green line); CD71 and involucrin
staining was weak in ABCG2-positive cells; both ABCG2-positive and
ABCG2-negative cells were unstained for CD34 and C-kit. Isotype
control, red line. (B, C) Colonies formed by ABCG2-positive
keratinocytes and ABCG2-negative keratinocytes. ABCG2-positive and
ABCG2-negative keratinocytes were sorted and seeded onto a lethally
irradiated 3T3 feeder layer, and allowed to grow for 7 days. (B) ABCG2-
positive keratinocytes formed a large colony, composed of small and
actively growing keratinocytes. (C) ABCG2-negative keratinocytes
formed small colonies, with irregular margin and big keratinocytes,
indicating an abortive colony. Scale bars: B, C, 100 μm.
Table 1 Mean fluorescence intensity of three groups of
keratinocyte stained with molecular markers
Marker ABCG2-positive ABCG2-negative Control
α6-integrin 89 ± 5.6 6.8 ± 0.6 7.2 ± 0.8
β1-integrin 663 ± 58.4 5.8 ± 0.7 6.3 ± 0.6
Keratin 14 557 ± 68.1 84 ± 70.4 9.5 ± 8.3
p63 398 ± 52.4 65 ± 7.8 8.8 ± 7.6
CD71 6.5 ± 0.7 6.9 ± 0.8 5.8 ± 0.4
Involucrin 5.3 ± 0.4 66 ± 5.7 4.9 ± 0.5
C-kit 8.4 ± 0.5 7.8 ± 0.6 6.3 ± 0.4
CD34 3.4 ± 0.2 4.1 ± 0.3 1.9 ± 0.3
Data presented as mean ± standard error of three biological replicates from
ABCG2-positive, ABCG2-negative and control group keratinocytes.
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basal layers in ABCG2-positive samples (Figure 4D), while
strong staining of involucrin was also detected in ABCG2-
negative groups (Figure 4E), but it is of early onset, sug-
gesting disorganization of differentiation and loss of ter-
minal differentiation. This result indicates that the
capacity for differentiation, as well as the clonogenic cap-
acity, is retained in ABCG2-positive keratinocytes, and
thus these two cell populations can be clearly distin-
guished on the basis of this functional test.
Transplantation of cultured epidermal grafts onto nude
mice
To determine the long-term epidermal regeneration cap-
acity of ABCG2-positive keratinocytes, ABCG2-positive
and ABCG2-negative keratinocytes were sorted and used
to prepared cultured epidermal grafts; unsorted kerati-
nocytes and α6-integrin-positive keratinocytes were also
used for comparison. These grafts were transplanted onto
dorsum full-thickness wounds in nude mice, and the take
of grafts was assessed and followed by histological analysis
(Figures 6 and 7). Immunostaining of anti-involucrinmonoclonal antibody was used to detect human grafts in
mouse skin samples (Figure 5B,C), and positive staining
(green) was observed in human grafts (single orange
arrow, Figure 5C) while no staining was observed in
mouse skin (double orange arrow, Figure 5B,C), and dis-
tinct separation was observed (black arrow, Figure 5B).
All grafts survived for the duration of transplantation,
and no signs of necrosis were observed (Figure 6). The
gross appearance of grafts changed from shiny (before
grafting) to whitish colored, which indicated the forma-
tion of stratum corneum on each graft, induced by con-
tact with air. All grafts from four groups of animals
showed no blistering, and the take rate was excellent.
However, the whitish-covered grafts in the ABCG2-
negative group were observed to be much thinner than
in the other three groups. Four weeks after grafting, per-
sistent human epidermis was observed in three of the
four groups (grafts derived from ABCG2+, a6-integrin+,
or unselected (control) cells), whereas in the ABCG2-
negative group the mouse epidermis was observed to
have populated the skin wound with thickened stratum
corneum and thinner epidermis (Figure 6). Eighteen
weeks after grafting, well organized human epidermis,
with all histological cell layers represented, was observed
in the ABCG2-positive, a6-integrin-positive and control
groups, which indicated the complete maturation and dif-
ferentiation of epidermal cells. In the ABCG2-positive
group, the epidermis consisted of 14 to 16 cell layers,
which is significantly thicker than those in the control and
a6-integrin groups (eight to 10 cell layers). Melanocytes
were also observed within the basal layer, and rete ridge
structures could also be seen. The staining of epidermal
differentiation markers, including involucrin and loricrin,
performed at 18 weeks after transplantation showed signs
of mature and well differentiated human epidermis (Fig-
ure 5). Interestingly, for the staining of the cell proliferat-
ing marker Ki-67, the ABCG2-positive group showed a
cluster of positive staining in basal keratinocytes, while
relatively sparse positive staining was observed in the
Figure 4 Colony-forming efficiency assay and skin organotypic assay. (A), (F) Colony-forming efficiency (CFE) of ABCG2-positive, ABCG2-
negative and unsorted keratinocytes. (A) ABCG2-positive and ABCG2-negative keratinocytes were sorted as in Figure 3, 100 cells of each population
were seeded in a 100 mm Petri dish preseeded with a lethally irradiated 3T3 feeder layer, and CFE was evaluated at day 12. (F) The ABCG2-positive
cells showed a greater number of colonies than the ABCG2-negative cells (CFE, 85% ± 2.1% vs. 27% ± 1.8%, P <0.01, n = 5), whereas there was no
difference between ABCG2-negative cells and unsorted cells (CFE, 27% ± 1.8% vs. 31 ± 2.3%, P >0.05, n = 5). (B) to (E) Epidermal reconstruction
(organotypic) assay of ABCG2-positive and ABCG2-negative keratinocytes. Human epidermal ABCG2-positive and ABCG2-negative keratinocytes were
sorted as in Figure 3 and plated onto a de-epidermized dermis (DED) substrate. (B) ABCG2-positive cells were seeded on top of DED; 1 week after
seeding, stratified epidermis was formed, with a typical stratum granulosum and stratum corneum. (C) ABCG2-negative cells were seeded on top of
DED; 1 week later, a disordered multilayered tissue had formed. Scale bars: 100 μm. (D) Immunostaining of involucrin in ABCG2-positive culture
showed strong positive staining (green) in the suprabasal layer. (E) Weak and abnormal staining for involucrin was detected in ABCG2-negative
culture. (G) Clonal analysis of ABCG2-positive epidermis keratinocytes. ABCG2-positive cells were sorted as in Figure 3, and a total of 300 single cells
from five donors were picked and inoculated into a 35 mm Petri dish preseeded with lethally irradiated 3 T3 cells. Seven days later, one-quarter of
each resulting colony was trypsinized, and transferred to an indicator dish. These dishes were fixed, stained and analyzed 12 days later. The holoclones,
meroclones and paraclones shown here are typical figures. Scale bars: D, E, 50 μm.
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suggests that there were more proliferative keratinocytes
within the basal layer of grafts derived from cells selected
as ABCG2-positive, compared with grafts derived from
the control (unfractionated keratinocytes) or the α6-
integrin-positive selected cells.Table 2 Clonogenic potential of ABCG2-positive versus ABCG
Keratinocyte clone ABCG2-positive cells
H M P
NK1213 75 20 5
NK0428 71.67 25 3
NK0609 73.33 18.33 8
NK0411 78.33 16.67 5
NK0914 70 23.33 6
Mean 73.67 ± 1.21 20.67 ± 1.55 5
Data presented as percentage or mean ± standard error. H, holoclone; M, meroclonDiscussion
This is the first report on the use of ABCG2 to isolate
progenitor-enriched cells from human interfollicular
epidermis. We show that, outside of the hair follicles,
ABCG2 transporter expression is restricted to the




.33 5 31.67 63.33
.34 1.67 26.67 71.67
1.67 30 68.33
.67 3.33 25 71.67
.67 ± 0.85 3 ± 0.62 29.67 ± 1.78 67.33 ± 2.08
e; P, paraclone.
Table 3 Proliferation capacity of primary ABCG2-positive











NK1213 3 23 140 ± 8 124.3 ± 1.8
NK0428 4 35 115 ± 12 136.2 ± 3.4
NK0609 3 45 130 ± 10 129.5 ± 2.2
NK0411 3 28 125 ± 12 131.8 ± 2.1
NK0914 4 46 135 ± 10 136.4 ± 2.7
Data presented as mean ± standard error. PD, population doublings.
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cytes account for 2.1 to 3.3% of the total basal epider-
mal keratinocytes. These cells are also p63-positive,
β1 integrin-positive, α6 integrin-positive, keratin14-
positive, CD34-negative, CD71-negative, C-kit-negative
and involucrin-negative. The ABCG2-positive keratinocytes
showed significantly higher CFE on 3T3 feeder layers than
ABCG2-negative keratinocytes. The ABCG2-positive kera-
tinocytes also showed extensive proliferative capacity in
long-term culture, and most of the freshly isolated ABCG2-
positive keratinocytes formed holoclones. They can also
form pluristratified epidermis in an organotypic culture
model. Our data indicate that ABCG2 is exclusively
expressed by a subset of basal keratinocytes in human
interfollicular epidermis, and that this population of cells
possesses properties of keratinocyte stem cells, suggestingFigure 5 Proliferation potential of primary keratinocytes in long-term
ABCG2-positive keratinocytes were sorted; holoclones, meroclones and par
irradiated 3T3 feeder layer until their growth potential was exhausted. Tripl
five keratinocyte clones were analyzed. The number of cumulative populat
doublings = (log N / N0) / log2, where N represents the total number of cel
cells at the beginning. H, holoclone; M, meroclone; P, paraclone. The image is
antibody was used to detect transplanted human grafts in mouse skin sample
arrow, C), while negative staining was observed in mouse skin (double orange
bars: B, C, 50 μm.that ABCG2 might be a useful marker for enriching for
keratinocyte stem cells in human interfollicular epidermis.
Previous studies have shown that ABCG2 expression
is present in both cytoplasm and cell membrane, and is
only found in stem cells [20,22,28,39,40]. Our immuno-
fluorescence staining and western blot analysis showed
that ABCG2 expression was specifically localized to
certain basal keratinocytes in human interfollicular epi-
dermis, a small subpopulation of the basal layer kerati-
nocytes, which is consistent with previous reports of
ABCG2 staining in mouse skin [32,39]. We found that
the proportion of ABCG2-expressing cells in interfolli-
cular epidermis keratinocytes was higher than in other
tissues examined, such as bone marrow, which was re-
ported to be 0.005 to 0.1% [21,23]. In vivo studies in
mice suggest that keratinocyte progenitor cells make up
around 4% of the basal layer keratinocytes [13]. Our data
of 2.1 to 3.3% ABCG2-positive keratinocytes is consist-
ent with these previous observations.
Many molecular markers for epithelial stem cells have
been investigated, including the transcription factor p63
[15], β1-integrin [3,4], α6-integrin and transferrin recep-
tor CD71 [13], CD34 [31,41], keratin 19 [12] and
ABCG2 [28]. We found that p63, β1-integrin, α6-
integrin and keratin 14 were highly expressed in
ABCG2-positive keratinocytes, while CD34, CD71, C-kit
and involucrin were weakly expressed. C-kit is reported
to be highly expressed in bone marrow stem cells, butculture and immunostaining of transplanted skin grafts. (A)
aclones were identified, and subcultured serially on a lethally
icate cultures in each keratinocyte clones were cultured, and a total of
ion doublings was calculated using the following formula: population
ls obtained at each passage and N0 represents the number of plating
a typical graph. (B), (C) Immunostaining of anti-involucrin monoclonal
s. Positive staining (red) was observed in human grafts (single orange
arrow, C), and distinct separation was observed (black arrow, B). Scale
Figure 6 Transplantation of cultured epidermal grafts onto nude mice. Human ABCG2-positive and ABCG2-negative keratinocytes were
sorted out and used to prepare cultured epidermal grafts; unsorted keratinocytes and α6-integrin-positive keratinocytes were also used for
comparison. All grafts survived for the duration of transplantation, and no signs of necrosis were observed. All grafts from four groups of animals
showed no blistering, and the take rate was excellent. However, the whitish-covered grafts in ABCG2-negative groups were observed to be much
thinner than in the other three groups. Four weeks after grafting, persistent human epidermis was observed in all groups except in the ABCG2-
negative group in which the mouse epidermis was observed to have populated the skin wound. Eighteen weeks after grafting, well
organized human epidermis, with all histological cell layers represented, was observed in ABCG2-positive, a6-integrin-positive and control groups,
which indicated the complete maturation and differentiation of epidermal cells. Melanocytes were also observed within the basal layer, and
distinct rete ridge structures could also be seen. Scale bars: 50 μm.
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[21,32]. CD34 was proven to be a marker for hair follicle
bulge keratinocyte stem cells in mouse [6,8,14], and a re-
cent report indicated that it was weakly expressed in hu-
man hair follicle keratinocyte stem cells [41]. Our data
for C-kit and CD34 were compatible with previous re-
ports. These results indicated that ABCG2-positiveFigure 7 Immunostaining of transplanted skin grafts at
18 weeks after transplantation. Staining of differentiation markers,
involucrin and loricrin, showed signs of mature and well differentiated
human epidermis (Figure 5). Interestingly, for the staining of the cell
proliferating marker Ki-67, the ABCG2-positive group showed a cluster
of positive staining in basal keratinocytes, while relatively sparse positive
staining was observed in the control and α6-integrin-positive groups.
Scale bars: 50 μm.keratinocytes express several potential stem cells markers;
this cell population shows a phenotype of basal layer kera-
tinocytes, and they are not differentiated keratinocytes.
Clonal analysis was used to evaluate keratinocyte
clones formed in vitro. According to the percentage of
aborted colonies form by the progeny of the seeding cell
[37], keratinocyte clones produced in tissue culture can
be categorized as holoclones, meroclones and para-
clones. Holoclones showed extensive proliferative poten-
tial in in vitro culture, with a mean population doubling
of 120 to 160 in human skin keratinocytes [37]. Recently,
a transplantation assay of holoclones in the rodent
model [42] indicated that holoclones maintained their
stemness and multipotentiality in tissue culture. There-
fore, holoclones can be considered as containing kera-
tinocyte stem cells [2,9,15,42]. Our data show that in the
ABCG2-positive keratinocyte population approximately
74% of cells were holoclones, while there was less than
5% of holoclones in ABCG2-negative cells. We feel
confident that ABCG2-positive keratinocytes exhibit a
major subset of keratinocyte stem cells in human inter-
follicular skin. Our results also showed that the ABCG2-
positive cells had population doublings of 120 to 140,
which is similar to the previous proliferative potential re-
port of holoclones [37].
With the in vitro epidermal reconstitution assay, we
demonstrate that the skin generated by ABCG2-positive
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epidermis, and a more well ordered epidermal structure
containing the stratum granulosum and stratum corneum,
than the skin generated by ABCG2-negative keratinocytes.
This finding indicates that ABCG2-positive keratinocytes
are not only capable of self-renewal but of giving rise to
hierarchical differentiating progeny, which are traits of
keratinocyte stem cells. The observed high proliferative
potential of ABCG2-positive keratinocytes, as indicated by
CFE assay and clonal analysis, suggests that these cells
may contribute to this enhanced skin thickness and well
ordered epidermis structure.
In previous studies, the ABCG2 transporter has been
suggested to be the molecular determinant of the SP cell
phenotype in many tissues [20,22,23]. However some
studies showed that ABCG2 might not characterize SP
keratinocytes [20,28,31,34], which were different from
the reports in other tissues and organs. The complex
and sensitive procedure of the Hoechst 33342 exclusion
assay may contribute to this controversy [28]. Also,
Hoechst 33342 is a DNA intercalating agent that results
in significant cellular toxicity, and may have caused
RNA degradation in the sorted cell population [39,43]. A
recent study also suggests that Hoechst 33342 could
affect cell differentiation [43], which could further com-
plicate the interpretation of SP keratinocyte studies. In
this study, we have concentrated on the expression of
ABCG2 in human interfollicular skin. We used a mono-
clonal antibody to ABCG2 (clone 5D3) to sort out ABCG2-
positive keratinocytes, which provides more stable and
consistent data than the Hoechst dye exclusion assay.
The robust identification of keratinocyte stem/
progenitor cells has major practical importance for gen-
erating a better characterization of the biochemical
properties, and growth and proliferation characteristics
of human interfollicular stem cells that sustain human
epidermis for many decades. The efficient selection of
clonogenic keratinocytes also has many valuable clinical
applications, such as in severe burns, corneal defect [44]
and stem cell therapy and gene therapy in recessive dys-
trophic epidermolysis bullosa patients [45]. Keratinocyte
stem cells have been identified in vivo by label retention
assays or in vitro by clonogenic assays [1,2,9]. However,
both of these methods are too destructive to be useful
for isolation and purification of viable keratinocyte stem
cells. On the other hand, many molecular markers have
been proposed to enrich for keratinocyte stem cells, in-
cluding p63, keratin 19, α6-integrin, β1-integrin, CD71,
desmoplakin, Rac1, MTS24 and survivin, or a combination
of cell kinetics and surface markers [3,12,13,15-18,46,47].
However, no single marker or method has been universally
adopted for identifying and isolating keratinocyte stem
cells, making the search for additional molecular markers
worth pursuing [19,46].Cultured epithelial grafts have been developed by cul-
turing keratinocytes in a Petri dish, on fibrin matrices or
on human/pig plasma [48-50]. The advantage of using a
fibrin matrix is that it maintains the stemness of kera-
tinocyte stem cells, which is most important for skin
transplantation and regeneration. In this study, pig
plasma was used to support keratinocyte growth and
served as a dermal scaffold for human fibroblasts. The
high long-term take rate of cultured human epidermal
grafts in nude mice suggests that this protocol allows
functional analysis of epidermal stem cells in vivo.
In this study, the human grafts derived from ABCG2-
positive, a6-integrin-positive and control keratinocytes
showed excellent take and survived up to 20 weeks.
After 12 weeks, the epidermis derived from ABCG2-
positive keratinocytes showed thicker epidermis cell
layers than in the control and α6-integrin-positive
groups. This difference might be related to the different
proportions of clonogenic cells present in the deriving
keratinocytes, as our previous results suggested high
proportions of clonogenic cells within the ABCG2-
positive population.
Conclusions
We have demonstrated that ABCG2-positive keratino-
cytes can be isolated from human skin interfollicular
epidermis, and that these cells have an undifferentiated
keratinocyte phenotype and retain a range of biomarkers
that suggest they can be interpreted as the interfollicular
(non-hair-follicle) stem cells of the epidermis. Since the
long-term durability of skin keratinocyte transplantation
depends on the reserve and maintenance of keratinocyte
stem cells in the skin grafts [50], the identification of
ABCG2-positive keratinocytes is expected to prove use-
ful for clinical applications, such as in wound healing
and generating better quality skin replacement.
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